A Comparison of the Acute Toxicity Profile between Two-dimensional and Three-dimensional Image-guided Radiotherapy for Postoperative Prostate Cancer

Clinical Oncology

Volumn 23, Issue 5, 2011, Pages 344-349

  Ost, P ^a   De Gersem, W ^a   De Potter, B ^a   Fonteyne, V ^a   De Neve, W ^a   De Meerleer, G ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

CBCT; IGRT; IMRT; Postoperative; Precision; Prostate

Indexed keywords

ABDOMINAL CRAMP; ALGORITHM; ARTICLE; CANCER RADIOTHERAPY; CONE BEAM COMPUTED TOMOGRAPHY; CONTROLLED STUDY; DYSURIA; GASTROINTESTINAL TOXICITY; HEMATURIA; HUMAN; HUMAN TISSUE; INCONTINENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL APPARATUS, EQUIPMENT AND SUPPLIES; NOCTURIA; PATIENT POSITIONING; PATIENT REFERRAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM HEMORRHAGE; THREE DIMENSIONAL IMAGING; URINARY URGENCY; UROGENITAL TRACT DISEASE;

CONE-BEAM COMPUTED TOMOGRAPHY; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 79955673050     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2011.01.505     Document Type: Article

References (32)

1. Ost P, De Troyer B, Fonteyne V, Oosterlinck W, De Meerleer G. A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010, http://doi:10.1016/j.ijrobp.2010.04.039.
2. Button M.R., Staffurth J.N. Clinical application of image-guided radiotherapy in bladder and prostate cancer. Clin Oncol (R Coll Radiol) 2010, 22:698-706.
3. Chinnaiyan P., Tomee W., Patel R., Chappell R., Ritter M. 3D-ultrasound guided radiation therapy in the post-prostatectomy setting. Technol Cancer Res Treat 2003, 2:455-458.
4. Kupelian P.A., Langen K.M., Willoughby T.R., Wagner T.H., Zeidan O.A., Meeks S.L. Daily variations in the position of the prostate bed in patients with prostate cancer receiving postoperative external beam radiation therapy. Int J Radiat Oncol Biol Phys 2006, 66:593-596.
5. Paskalev K., Feigenberg S., Jacob R., et al. Target localization for post-prostatectomy patients using CT and ultrasound image guidance. J Appl Clin Med Phys 2005, 6:40-49.
6. Sandhu A., Sethi R., Rice R., et al. Prostate bed localization with image-guided approach using on-board imaging: reporting acute toxicity and implications for radiation therapy planning following prostatectomy. Radiother Oncol 2008, 88:20-25.
7. Schiffner D.C., Gottschalk A.R., Lometti M., et al. Daily electronic portal imaging of implanted gold seed fiducials in patients undergoing radiotherapy after radical prostatectomy. Int J Radiat Oncol Biol Phys 2007, 67:610-619.
8. Ost P., De Meerleer G., De Gersem W., Impens A., De Neve W. Analysis of prostate bed motion using daily cone-beam computed tomography during postprostatectomy radiotherapy. Int J Radiat Oncol Biol Phys 2010.
9. Fiorino C., Foppiano F., Franzone P., et al. Rectal and bladder motion during conformal radiotherapy after radical prostatectomy. Radiother Oncol 2005, 74:187-195.
10. Haworth A., Paneghel A., Herschtal A., et al. Verification of target position in the post-prostatectomy cancer patient using cone beam CT. J Med Imaging Radiat Oncol 2009, 53:212-220.
11. Showalter T.N., Nawaz A.O., Xiao Y., Galvin J.M., Valicenti R.K. A cone beam CT-based study for clinical target definition using pelvic anatomy during postprostatectomy radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70:431-436.
12. De Meerleer G., Vakaet L., De Gersem W., Villeirs G., De Neve W. Direct segment aperture and weight optimization for intensity-modulated radiotherapy of prostate cancer. Strahlenther Onkol 2004, 180:136-143.
13. De Meerleer G., Vakaet L., Meersschout S., et al. Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients. Int J Radiat Oncol Biol Phys 2004, 60:777-787.
14. De Meerleer G.O., Vakaet L.A., De Gersem W.R., De Wagter C., De Naeyer B., De Neve W. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int J Radiat Oncol Biol Phys 2000, 47:639-648.
15. De Meerleer G., Fonteyne V., Meersschout S., et al. Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy. Radiother Oncol 2008, 89:205-213.
16. Diot Q, Olsen C, Kavanagh B, Raben D, Miften M. Dosimetric effect of online image-guided anatomical interventions for postprostatectomy cancer patients. Int J Radiat Oncol Biol Phys 2010, http://doi:10.1016/j.ijrobp.2010.04.020.
17. Diot Q., Olsen C., Kavanagh B., Raben D., Miften M. Impact of anatomical interventions on the localization of post-prostatectomy cancer patients. Med Phys 2010, 37:629-637.
18. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995, 31:1341-1346.
19. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003, 13:176-181.
20. Lent Soma tables. Radiother Oncol 1995, 35:17-60.
21. Fonteyne V., De Neve W., Villeirs G., De Wagter C., De Meerleer G. Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity. Radiother Oncol 2007, 84:156-163.
22. Jereczek-Fossa B.A., Zerini D., Vavassori A., et al. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy. Int J Radiat Oncol Biol Phys 2008.
23. Pearse M., Choo R., Danjoux C., et al. Prospective assessment of gastrointestinal and genitourinary toxicity of salvage radiotherapy for patients with prostate-specific antigen relapse or local recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys 2008, 72:792-798.
24. Teh B.S., Mai W.Y., Augspurger M.E., et al. Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. Int J Radiat Oncol Biol Phys 2001, 49:465-472.
25. Nath S.K., Sandhu A.P., Rose B.S., et al. Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2009.
26. Harsolia A., Vargas C., Yan D., et al. Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study. Int J Radiat Oncol Biol Phys 2007, 69:1100-1109.
27. Jereczek-Fossa BA, Zerini D, Fodor C, et al. Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy. Int J Radiat Oncol Biol Phys 2010, http://doi:10.1016/j.ijrobp.2009.07.1742.
28. Liu M., Pickles T., Agranovich A., et al. Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy. Int J Radiat Oncol Biol Phys 2004, 58:59-67.
29. Schultheiss T.E., Lee W.R., Hunt M.A., Hanlon A.L., Peter R.S., Hanks G.E. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997, 37:3-11.
30. Zelefsky M.J., Cowen D., Fuks Z., et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 1999, 85:2460-2468.
31. Villeirs G.M., De Meerleer G.O., Verstraete K.L., De Neve W.J. Magnetic resonance assessment of prostate localization variability in intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2004, 60:1611-1621.
32. Walz J., Burnett A.L., Costello A.J., et al. A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol 2010, 57:179-192.